Many ways to make an influenza virus – review of influenza virus reverse genetics methods

por Engelhardt, Othmar G.
Publicado 2012

Developing Vaccines to Combat Pandemic Influenza

por Robertson, James S., Engelhardt, Othmar G.
Publicado 2010

The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein

por Nicolson, Carolyn, Harvey, Ruth, Engelhardt, Othmar G., Robertson, James S.
Publicado 2016

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study

por McDonald, Jacqueline U., Rigsby, Peter, Dougall, Thomas, Engelhardt, Othmar G.
Publicado 2018

Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy

por Tung Yep, Andrew, Takeuchi, Yasu, Engelhardt, Othmar G., Hufton, Simon E.
Publicado 2021

The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation p...

por Van Kerkhove, Maria D., Broberg, Eeva, Engelhardt, Othmar G., Wood, John, Nicoll, Angus
Publicado 2012

Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14

por Johnson, Rachel E., Hamill, Michelle, Harvey, Ruth, Nicolson, Carolyn, Robertson, James S., Engelhardt, Othmar G.
Publicado 2012

Correction: Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14

por Johnson, Rachel E., Hamill, Michelle, Harvey, Ruth, Nicolson, Carolyn, Robertson, James S., Engelhardt, Othmar G.
Publicado 2012

A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine

por Harvey, Ruth, Johnson, Rachel E, MacLellan-Gibson, Kirsty, Robertson, James S, Engelhardt, Othmar G
Publicado 2014

The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency

por Hufton, Simon E., Risley, Paul, Ball, Christina R., Major, Diane, Engelhardt, Othmar G., Poole, Stephen
Publicado 2014

Workshop report: Immunoassay standardisation for “universal” influenza vaccines

por Pavlova, Sophia, D'Alessio, Flavia, Houard, Sophie, Remarque, Edmond J., Stockhofe, Norbert, Engelhardt, Othmar G.
Publicado 2017

Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display

por Gaiotto, Tiziano, Ramage, Walter, Ball, Christina, Risley, Paul, Carnell, George W., Temperton, Nigel, Engelhardt, Othmar G., Hufton, Simon E.
Publicado 2021

Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses

por Chen, Li‐Mei, Donis, Ruben O., Suarez, David L., Wentworth, David E., Webby, Richard, Engelhardt, Othmar G., Swayne, David E.
Publicado 2019

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin

por Ramage, Walter, Gaiotto, Tiziano, Ball, Christina, Risley, Paul, Carnell, George W., Temperton, Nigel, Cheung, Chung Y., Engelhardt, Othmar G., Hufton, Simon E.
Publicado 2019

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity

por Del Rosario, Joanne Marie M., Smith, Matthew, Zaki, Kam, Risley, Paul, Temperton, Nigel, Engelhardt, Othmar G., Collins, Mary, Takeuchi, Yasuhiro, Hufton, Simon E.
Publicado 2020

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies

por Cheung, Chung Y., Dubey, Sitara, Hadrovic, Martina, Ball, Christina R., Ramage, Walter, McDonald, Jacqueline U., Harvey, Ruth, Hufton, Simon E., Engelhardt, Othmar G.
Publicado 2022

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE

por Laurie, Karen L., Engelhardt, Othmar G., Wood, John, Heath, Alan, Katz, Jacqueline M., Peiris, Malik, Hoschler, Katja, Hungnes, Olav, Zhang, Wenqing, Van Kerkhove, Maria D.
Publicado 2015

Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses

por Hussain, Saira, Turnbull, Matthew L., Wise, Helen M., Jagger, Brett W., Beard, Philippa M., Kovacikova, Kristina, Taubenberger, Jeffery K., Vervelde, Lonneke, Engelhardt, Othmar G., Digard, Paul
Publicado 2019

CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement

por Horby, Peter W., Laurie, Karen L., Cowling, Benjamin J., Engelhardt, Othmar G., Sturm‐Ramirez, Katharine, Sanchez, Jose L., Katz, Jacqueline M., Uyeki, Timothy M., Wood, John, Van Kerkhove, Maria D.
Publicado 2016

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

por Bhide, Yoshita, Dong, Wei, Gribonika, Inta, Voshart, Daniëlle, Meijerhof, Tjarko, de Vries-Idema, Jacqueline, Norley, Stephen, Guilfoyle, Kate, Skeldon, Sarah, Engelhardt, Othmar G., Boon, Louis, Christensen, Dennis, Lycke, Nils, Huckriede, Anke
Publicado 2019